LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Kodu・Aktsiate loetelu・Illumina Inc

Search

Illumina Inc

Avatud

Sektor Tervishoid

153.8 2.67

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

148.74

Max

155.16

Põhinäitajad
By Trading Economics
Sissetulek	-1.9B -2B
Müük	30M 1.1B
Aktsiakasum	0.36
Kasumimarginaal	-179.099
Töötajad	10,590
EBITDA	-1.9B -1.9B

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+5.09 upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	4. nov 2024

Turustatistika
By TradingEconomics
Turukapital	478M 23B
Eelmine avamishind	151.13
Eelmine sulgemishind	153.8

Uudiste sentiment

By Acuity

36%

64%

122 / 390 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

142.9 / N/A Toetus ja vastupanu

Illumina Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. dets 2023, 18:43 UTC

Omandamised, ülevõtmised, äriostud

Illumina Submits SEC Form For Grail Divestiture

5. märts 2024, 08:00 UTC

Tulu

Earnings Season Is Wrapping Up. Who Came Out Ahead, in 6 Charts. -- Barrons.com

18. dets 2023, 23:17 UTC

Omandamised, ülevõtmised, äriostud

Antitrust Regulators Issue New Merger Rules Amid Crackdown -- Barrons.com

18. dets 2023, 20:33 UTC

Omandamised, ülevõtmised, äriostud

Adobe-Figma Breakup Isn't Just a Win for Regulators. Why Consumers Should Be Cheering Too. -- Barrons.com

18. dets 2023, 09:48 UTC

Omandamised, ülevõtmised, äriostud

Illumina to Sell Grail. It's Giving Up on its Biotech Antitrust Battle. -- Barrons.com

18. dets 2023, 09:34 UTC

Omandamised, ülevõtmised, äriostud

These Stocks Are Moving the Most Today: Illumina, Roku, Uber, Broadcom, and More -- Barrons.com

9. nov 2023, 09:39 UTC

Tulu

These Stocks Are Moving the Most Today: Disney, Arm, Applovin, Affirm, Topgolf Callaway, and More -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

Illumina Inc Prognoos

Hinnasiht

By TipRanks

5.09% tõus

12 kuu keskmine prognoos

Keskmine 157.38 USD 5.09%

Kõrge 252 USD

Madal 105 USD

Põhineb 16 Wall Streeti analüütiku instrumendi Illumina Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

16 ratings

10

Osta

5

Hoia

1

Müü

Põhineb 16 analüütiku instrumendi Illumina Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

142.9 / N/AToetus ja vastupanu

Recent bullish events outweigh bearish events.

All events are bullish.

Recent bullish events outweigh bearish events.

Sentiment

By Acuity

122 / 390 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Illumina Inc

Illumina, Inc. (Illumina) is a provider of sequencing- and array-based solutions. The Company operates through segments such as Core Illumina. Core Illumina’s products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Core Illumina consists of its core operations. The Company's portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed for genetic analysis. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.

Muud aktsiad sektorist

LLY

Eli Lilly and Co.

805.71

UNH

UnitedHealth Group Inc

556.95

JNJ

Johnson and Johnson

158.12

NVO

Novo Nordisk A-S

109.92

ABBV

AbbVie Inc

200.71